- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$2.70 BnMarket Estimate, 2026
$3.61 BnMarket Forecast, 2034
$37.31 BnCAGR, 2026–2034
33.88%Executive Summary: North America Digital Therapeutics Market
- Market Scope: Comprehensive North American digital therapeutics (DTx) market analysis covering product categories (software, devices), sales channels (B2C and B2B segments spanning providers, payers, and employers), diverse preventive and treatment applications, and country-level developments across the United States, Canada, and Mexico.
- Market Valuation: Valued at USD 2.70 billion (2025), estimated at USD 3.61 billion in 2026, and projected to reach USD 37.31 billion by 2034, registering a robust CAGR of 33.88% (2026–2034).
- Primary Growth Drivers: High smartphone and tablet adoption rates, expanding 4G/5G mobile health infrastructure, rising prevalence of chronic conditions like diabetes and obesity, and increasing collaboration between biopharma giants and digital health innovators.
Key Market Segment Metrics (2026–2034)
| Category | Leading Segment (2025 Position) | Fastest-Growing Segment |
|---|---|---|
| By Product | Software Platforms (commanding a major share via evidence-based apps, virtual care interfaces, and remote monitoring systems) | Integrated Hardware Devices & Smart Wearables (scaling rapidly through real-time biometric tracking and clinical feedback) |
| By Sales Channel | Business-to-Business (B2B) (holding the largest share through provider, payer, and employer-sponsored health plans) | Direct-to-Consumer (B2C) (expanding via self-managed wellness, caregiver tools, and patient-purchased subscriptions) |
| By Application | Treatment & Care Management (dominating due to high patient demand for diabetes, CNS, and chronic disease management) | Preventive Applications (growing swiftly driven by prediabetes, obesity, nutrition, and lifestyle management initiatives) |
| By Country | United States (top regional revenue contributor backed by FDA digital health pathways, venture funding, and high chronic illness care expenditures) | Canada & Mexico (experiencing accelerated adoption through telehealth modernization and national digital health strategies) |
Major Market Players & Market Structure
Market Structure: Highly dynamic ecosystem characterized by digital health pioneers, medical device leaders, and strategic alliances navigating complex data security protocols, evolving reimbursement frameworks, and FDA breakthrough device designations.
Key Companies: 2Morrow, Inc., Pear Therapeutics, Inc., Fitbit, Inc. (Twine Health, Inc.), Proteus Digital Health, Inc., Livongo Health, Inc., ResMed, Inc. (Propeller Health), Voluntis, Inc., Omada Health, Inc., Welldoc, Inc., and Medtronic Plc.
North America Digital Therapeutics Market Size
The North America digital therapeutics market was valued at USD 2.70 billion in 2025, is estimated to reach USD 3.61 billion in 2026, and is projected to reach USD 37.31 billion by 2034, growing at a CAGR of 33.88% from 2026 to 2034.
MARKET DRIVERS
Smartphone Adoption and Tech-Driven Chronic Disease Management
The rise in smartphone usage and tablets in the North American region is primarily driving the digital therapeutics market during the forecast period in this region. The increase in the adoption of 4G and the highest smartphone usage in this region is further estimated to boost the market's growth rate. The increasing prevalence of chronic diseases such as diabetes drives the North America Digital Therapeutics Market (DTx). The low cost associated with digital therapeutics treatment, the rise in awareness of smart health tracking, increasing expenditure, and the launch of new products & software are estimated to fuel the market growth. In addition, the rise in technological advancements to give transformational healthcare solutions propels the market growth. For instance, ATAI Life Sciences, in June 2020, launched IntroSpect Digital Therapeutics platform. Moreover, biopharmaceutical companies and digital therapeutic providers collaborate to provide a better quality of care for patients.
MARKET RESTRAINTS
Data Security Issues and Unstable Reimbursement Models
Cybersecurity poses a significant threat to databases. The hackers may hack the digital platforms and get all the private data related to the patients. Hence, the security and privacy concerns of the patient's medical data hamper the market growth. In addition, the lack of reimbursement policies for digital therapeutics is restraining the North American digital therapeutics market. Moreover, traditional healthcare providers will negatively affect market growth during the forecast period. The significant concern would be the lack of access to proper technology, leading to people's low awareness about the advantages of these applications. The unstable payment models in the North American digital therapeutics market are further forecasted to hinder the market growth.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| Segments Covered | By Product, Sales Channel, Application, and Region. |
| Various Analyses Covered | Global, Regional and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Countries Covered | United States, Canada, Mexico, Rest of North America |
| Market Leaders Profiled | 2Morrow, Inc., Pear Therapeutics, Inc., Fitbit, Inc. (Twine Health, Inc.), Proteus Digital Health, Inc., Livongo Health, Inc., Resmed, Inc. (Propeller Health), Voluntis, Inc., Omada Health, Inc. and Welldoc, Inc., and Medtronic Plc. |
REGIONAL ANALYSIS
Geographically, the size of the North American digital therapeutics market is expected to grow at a healthy rate. The rise in the usage of smartphones and smart wearables is driving the North American digital therapeutics market. In addition, the United States has the most elderly population. Old-age people prefer to be treated at home without going to hospitals for minor problems, which propelled the market. Moreover, the rise in the research and development activities for digital therapeutics devices boosts the market growth. For instance, in February 2019, Cognoa received the Breakthrough Device Designation from the Food and Drug Administration (FDA) for digital diagnostic and digital therapeutic devices for autism. The rise in adoption and awareness of Digital Therapeutics is propelling the market growth. Due to the surge in demand for Digital Therapeutics devices, the market has welcomed new market players, driving the market to grow. Further, the rise in the prevalence of chronic diseases in the United States is boosting the market. For instance, in the U.S, seven out of 10 deaths are accounted for chronic diseases, and the U.S. spends approximately 75% of the $2.2 trillion each year on chronic diseases.
KEY MARKET PLAYERS
Companies such as 2Morrow, Inc., Pear Therapeutics, Inc., Fitbit, Inc. (Twine Health, Inc.), Proteus Digital Health, Inc., Livongo Health, Inc., Resmed, Inc. (Propeller Health), Voluntis, Inc., Omada Health, Inc. and Welldoc, Inc., and Medtronic Plc are playing a leading role in the North America digital therapeutics market.
MARKET SEGMENTATION
This research report on the North American digital therapeutics market has been segmented and sub-segmented into the following categories.
By Product
- Software
- Device
- Others
By Sales Channel
- B2C
- Patients
- Caregivers
- B2B
- Providers
- Payers
- Employers
- Pharmaceutical Companies
- Other Buyers
By Application
- Preventive Applications
- Prediabetes
- Obesity
- Nutrition
- Lifestyle Management
- Other Preventive Applications
- Treatment/Care-related Applications
- Diabetes
- CNS Disorders
- Chronic Respiratory Disorders
- Musculoskeletal Disorders
- Cardiovascular Diseases
- Smoking Cessation
- Medication Adherence
- Gastrointestinal Disorders
- Substance Use & Addiction Management
- Rehabilitation & Patient Care
- Other Treatment/Care-related Applications
By Country
- The United States
- Canada
- Rest of North America